Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert M Ward

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Clinical Pharmacokinetics|July 12, 2011
Randomized, open-label, multicentre pharmacokinetic studies of two dose levels of pantoprazole granules in infants and children aged 1 month through <6 years with gastro-oesophageal reflux diseaseBrinda K Tammara, Janice E Sullivan, Kim G Adcock, et al.
The Pediatric Infectious Disease Journal|February 4, 2012
Therapeutic monitoring of voriconazole in children less than three years of age: a case report and summary of voriconazole concentrations for ten childrenElizabeth H Doby, Daniel K Benjamin, Anne J Blaschke, et al.
The Pediatric Infectious Disease Journal|July 14, 2009
Fluconazole dosing for the prevention or treatment of invasive candidiasis in young infantsKelly C Wade, Daniel K Benjamin, David A Kaufman, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 14, 2021
Treatment optimization of maintenance immunosuppressive agents in pediatric renal transplant recipientsKathleen M Job, Jessica K Roberts, Elena Y Enioutina, et al.
Current Clinical Pharmacology|September 30, 2015
Pharmacokinetics of Budesonide Administered with Surfactant in Premature Lambs: Implications for Neonatal Clinical TrialsJessica K Roberts, Chris Stockmann, Mar Janna Dahl, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|September 25, 2015
A propensity-matched cohort study of vancomycin-associated nephrotoxicity in neonatesJonathan E Constance, Alfred H Balch, Chris Stockmann, et al.
American Journal of Perinatology|December 11, 2008
A randomized, double-blind, placebo-controlled trial on intravenous ibuprofen L-lysine for the early closure of nonsymptomatic patent ductus arteriosus within 72 hours of birth in extremely low-birth-weight infantsJacob V Aranda, Ronald Clyman, Blair Cox, et al.
Journal of Clinical Pharmacology|September 21, 2010
A multicenter, randomized, open-label, pharmacokinetics and safety study of pantoprazole tablets in children and adolescents aged 6 through 16 years with gastroesophageal reflux diseaseRobert M Ward, Gregory L Kearns, Brinda Tammara, et al.
Pediatric Research|February 2, 2020
Dose-escalation trial of budesonide in surfactant for prevention of bronchopulmonary dysplasia in extremely low gestational age high-risk newborns (SASSIE)Cindy T McEvoy, Philip L Ballard, Robert M Ward, et al.
JMIR Research Protocols|May 22, 2023
Mapping the Evidence for Opioid-Mediated Changes in Malignancy and Chemotherapeutic Efficacy: Protocol for a Scoping ReviewJonathan E Constance, Mary M McFarland, Tallie Casucci, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Clinical Pharmacokinetics|July 12, 2011
Randomized, open-label, multicentre pharmacokinetic studies of two dose levels of pantoprazole granules in infants and children aged 1 month through <6 years with gastro-oesophageal reflux diseaseBrinda K Tammara, Janice E Sullivan, Kim G Adcock, et al.
The Pediatric Infectious Disease Journal|February 4, 2012
Therapeutic monitoring of voriconazole in children less than three years of age: a case report and summary of voriconazole concentrations for ten childrenElizabeth H Doby, Daniel K Benjamin, Anne J Blaschke, et al.
The Pediatric Infectious Disease Journal|July 14, 2009
Fluconazole dosing for the prevention or treatment of invasive candidiasis in young infantsKelly C Wade, Daniel K Benjamin, David A Kaufman, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 14, 2021
Treatment optimization of maintenance immunosuppressive agents in pediatric renal transplant recipientsKathleen M Job, Jessica K Roberts, Elena Y Enioutina, et al.
Current Clinical Pharmacology|September 30, 2015
Pharmacokinetics of Budesonide Administered with Surfactant in Premature Lambs: Implications for Neonatal Clinical TrialsJessica K Roberts, Chris Stockmann, Mar Janna Dahl, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|September 25, 2015
A propensity-matched cohort study of vancomycin-associated nephrotoxicity in neonatesJonathan E Constance, Alfred H Balch, Chris Stockmann, et al.
American Journal of Perinatology|December 11, 2008
A randomized, double-blind, placebo-controlled trial on intravenous ibuprofen L-lysine for the early closure of nonsymptomatic patent ductus arteriosus within 72 hours of birth in extremely low-birth-weight infantsJacob V Aranda, Ronald Clyman, Blair Cox, et al.
Journal of Clinical Pharmacology|September 21, 2010
A multicenter, randomized, open-label, pharmacokinetics and safety study of pantoprazole tablets in children and adolescents aged 6 through 16 years with gastroesophageal reflux diseaseRobert M Ward, Gregory L Kearns, Brinda Tammara, et al.
Pediatric Research|February 2, 2020
Dose-escalation trial of budesonide in surfactant for prevention of bronchopulmonary dysplasia in extremely low gestational age high-risk newborns (SASSIE)Cindy T McEvoy, Philip L Ballard, Robert M Ward, et al.
JMIR Research Protocols|May 22, 2023
Mapping the Evidence for Opioid-Mediated Changes in Malignancy and Chemotherapeutic Efficacy: Protocol for a Scoping ReviewJonathan E Constance, Mary M McFarland, Tallie Casucci, et al.
Pageof 8